miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development

被引：0
|
作者：
Mathieu Latreille
Karolin Herrmanns
Neil Renwick
Thomas Tuschl
Maciej T. Malecki
Mark I. McCarthy
Katharine R. Owen
Thomas Rülicke
Markus Stoffel
机构：
[1] Swiss Federal Institute of Technology (ETH Zurich),Institute of Molecular Health Sciences
[2] Hammersmith Hospital Campus,MRC Clinical Sciences Centre, Imperial College London
[3] The Rockefeller University,Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology
[4] Jagiellonian University Medical College,Department of Metabolic Diseases
[5] University Hospital,Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital
[6] University of Oxford,Wellcome Trust Centre for Human Genetics
[7] University of Oxford,Oxford NIHR Biomedical Research Centre
[8] Churchill Hospital,Institute of Laboratory Animal Science
[9] University of Veterinary Medicine,Faculty of Medicine
[10] University of Zurich,undefined
来源：
Journal of Molecular Medicine | 2015年 / 93卷
关键词：
MiRNA-375; Pancreatic β-cells; Biomarker; Diabetes; β-cell mass;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1159 / 1169
页数：10
相关论文
共 50 条
  • [1] miR-375 gene dosage in pancreatic 13-cells: implications for regulation of β-cell mass and biomarker development
    Latreille, Mathieu
    Herrmanns, Karolin
    Renwick, Neil
    Tuschl, Thomas
    Malecki, Maciej T.
    McCarthy, Mark I.
    Owen, Katharine R.
    Ruelicke, Thomas
    Stoffel, Markus
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (10): : 1159 - 1169
  • [2] miR-375 maintains normal pancreatic α- and β-cell mass
    Poy, Matthew N.
    Hausser, Jean
    Trajkovski, Mirko
    Braun, Matthias
    Collins, Stephan
    Rorsman, Patrik
    Zavolan, Mihaela
    Stoffel, Markus
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5813 - 5818
  • [3] Dual regulation of miR-375 and CREM genes in pancreatic beta cells
    Keller, David M.
    Perez, Isis G.
    ISLETS, 2022, 14 (01) : 139 - 148
  • [4] Circulating miR-375 as a Biomarker of β-Cell Death and Diabetes in Mice
    Erener, Suheda
    Mojibian, Majid
    Fox, Jessica K.
    Denroche, Heather C.
    Kieffer, Timothy J.
    ENDOCRINOLOGY, 2013, 154 (02) : 603 - 608
  • [5] The involvement of miR-375 in the adriamycin resistance of pancreatic carcinoma cells
    Lei, Changjiang
    Jiang, Xuan
    Song, Wenli
    Cheng, Cuinian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11394 - 11403
  • [6] The regulatory role of miR-375 in the pancreatic beta cell secretome
    Tattikota, S.
    Sury, M.
    Rathjen, T.
    Becker, C.
    Selbach, M.
    Poy, M.
    DIABETOLOGIA, 2012, 55 : S94 - S94
  • [7] miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1
    Zhang, Zhen-Wu
    Men, Tong
    Feng, Rui-Cheng
    Li, Yun-Chao
    Zhou, Di
    Teng, Chun-Bo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (06) : 1808 - 1817
  • [8] Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer
    Yu, Hong
    Jiang, Lin
    Sun, Canlin
    Guo, Lingchuan
    Lin, Mei
    Huang, Junxing
    Zhu, Li
    GENE, 2014, 534 (01) : 60 - 65
  • [9] Epigenetic regulation of miR-375 in human colorectal cancer cells: a key role of DNA methylation
    Chen, Beibei
    Chen, Xiaobing
    Yang, Jiao
    Zhou, Wenping
    Zhu, Caihua
    Fan, Xinxin
    Huang, Jinxi
    Li, Dan
    Cao, Xinguang
    Luo, Suxia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 19256 - 19267
  • [10] MiR-375 attenuates sorafenib resistance of hepatocellular carcinoma cells by inhibiting cell autophagy
    Wang, Dan
    Yang, Jingbo
    ACTA BIOCHIMICA POLONICA, 2023, 70 (02) : 239 - 246
12345